Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
Science Advances · 27.01.2023 · 9 (4)
DOI: 10.1126/sciadv.ade1444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 27.01.2023. Verfasst von Jilian R Melamed und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Nanoparticles. Die Arbeit wurde bisher 223-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Systemic messenger RNA (mRNA) delivery to organs outside the liver, spleen, and lungs remains challenging. To overcome this issue, we hypothesized that altering nanoparticle chemistry and administration routes may enable mRNA-induced protein expression outside of the reticuloendothelial system. Here, we describe a strategy for delivering mRNA potently and specifically to the pancreas using lipid nanoparticles. Our results show that delivering lipid nanoparticles containing cationic helper lipids by intraperitoneal administration produces robust and specific protein expression in the pancreas. Most resultant protein expression occurred within insulin-producing β cells. Last, we found that pancreatic mRNA delivery was dependent on horizontal gene transfer by peritoneal macrophage exosome secretion, an underappreciated mechanism that influences the delivery of mRNA lipid nanoparticles. We anticipate that this strategy will enable gene therapies for intractable pancreatic diseases such as diabetes and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
ORCID-Profile: Jilian R Melamed, Mariah L Arral, Namit Chaudhary, Anuradha Sehrawat, Hiromi Muramatsu, Norbert Pardi, Drew Weissman, George K Gittes, Kathryn A Whitehead
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- NICHD NIH HHS
Zitieren
APA
Melamed, J. R., Yerneni, S. S., Arral, M. L., LoPresti, S. T., Chaudhary, N., Sehrawat, A., Muramatsu, H., Alameh, M. G., Pardi, N., Weissman, D., Gittes, G. K., & Whitehead, K. A. (2023). Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer. Science Advances, 9(4). https://doi.org/10.1126/sciadv.ade1444
Vancouver
Melamed JR, Yerneni SS, Arral ML, LoPresti ST, Chaudhary N, Sehrawat A, et al. Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer. Science Advances. 2023;9(4). doi:10.1126/sciadv.ade1444
BibTeX
@article{Melamed2023,
author = {Melamed, Jilian R and Yerneni, Saigopalakrishna S and Arral, Mariah L and LoPresti, Samuel T and Chaudhary, Namit and Sehrawat, Anuradha and Muramatsu, Hiromi and Alameh, Mohamad-Gabriel and Pardi, Norbert and Weissman, Drew and Gittes, George K and Whitehead, Kathryn A},
title = {Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {4},
doi = {10.1126/sciadv.ade1444}
}
EUVIMED